This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Complications peculiar to reattachment and amputation
ST19_COMPLICATIO_PECUL_REATTACHM_AMPUT
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
237 |
4. Check minimum number of eventsNone |
237 |
5. Include endpointsNone |
237 |
6. Filter based on genotype QC (FinnGen only) |
237 |
Control definitions (FinnGen only)
- Control exclude
- ST19_COMPLICATIO_SURGI_MEDICAL_CARE_NOT_ELSEW_CLASSIFIED
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T8
- Name in latin
- Complicationes specificae recompingendi et amputationis
Similar endpoints
↥List of similar endpoints to
Complications peculiar to reattachment and amputation
based on the number of shared cases.
Similar with more cases:
- Complications of surgical and medical care, not elsewhere classified
- Injury, poisoning and certain other consequences of external causes
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 237 | 92 | 145 |
| Unadjusted period prevalence (%) | 0.05 | 0.03 | 0.06 |
| Median age at first event (years) | 63.80 | 60.96 | 65.61 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 217
- Matched controls
- 2168
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T87.4
ICD-10 Finland
Infection of amputation stump
+∞
137.5
117
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
21.3
74.2
122
123
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
126.0
72.6
75
9
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
41.8
71.6
90
36
NGQ20
NOMESCO Finland
Amputation of lower leg
300.1
66.2
64
*
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
87.0
65.4
71
12
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
98.0
63.7
68
10
T87.6
ICD-10 Finland
Other and unspecified complications of amputation stump
+∞
56.8
52
*
NHQ40
NOMESCO Finland
Amputation of toe
56.0
54.8
64
16
S97
ICPC
Chronic ulcer skin
23.9
48.6
71
43
NFQ20
NOMESCO Finland
Amputation of femur
203.9
48.0
48
*
J01FF01
ATC
clindamycin; systemic
9.0
47.2
133
324
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
26.2
45.4
64
34
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
28.3
39.5
54
25
ZXD05
NOMESCO Finland
Urgent procedure
7.0
38.6
137
426
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
83.6
37.5
41
6
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
94.1
36.2
39
5
SPAT1148
SPAT
Treatment of chronic ulcer or burn
8.3
33.6
85
156
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
11.8
32.7
64
74
A46
ICD-10 Finland
Erysipelas
7.4
31.1
86
177
ZZA00
NOMESCO Finland
Split skin graft
25.2
30.6
43
21
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
14.0
30.5
54
50
X59
ICD-10 Finland
Exposure to unspecified factor
7.1
30.4
87
187
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
26.6
25
*
TQW11
NOMESCO Finland
Vacuum treatment of wound
38.5
26.4
33
10
N03AX16
ATC
pregabalin; oral
5.6
26.2
93
255
C03CA01
ATC
furosemide; systemic
4.8
25.9
130
515
L89
ICD-10 Finland
Decubitus ulcer and pressure area
25.8
25.3
35
16
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
39.8
25.0
31
9
T87.3
ICD-10 Finland
Neuroma of amputation stump
+∞
24.4
23
*
NGQ48
NOMESCO Finland
Revision of exarticulation or amputation stump of knee or lower leg
268.2
24.1
24
*
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
41.5
23.7
29
8
N02AX02
ATC
tramadol; systemic, rectal
4.4
23.4
136
600
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
5.6
23.0
78
198
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
70.1
22.4
25
*
ZXA00
NOMESCO Finland
Right side
4.5
22.1
104
371
A10AE04
ATC
insulin glargine; parenteral
6.6
21.9
62
124
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
7.1
21.7
57
103
J01MA02
ATC
ciprofloxacin; systemic
4.1
21.4
129
572
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
+∞
21.2
20
*
WX213
NOMESCO Finland
Lower leg blockade
63.8
20.3
23
*
ZXA05
NOMESCO Finland
Left side
4.3
20.2
96
339
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
8.2
20.0
47
71
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.3
20.0
70
180
Z89.5
ICD-10 Finland
Acquired absence of leg at or below knee
219.0
19.9
20
*
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
22.7
19.6
28
14
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
25.5
19.6
27
12
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
60.8
19.3
22
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.8
19.1
59
130
N02AA05
ATC
oxycodone; systemic
5.1
19.1
69
183
WX212
NOMESCO Finland
Femoral plexus blockade
19.9
18.8
28
16
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
6.4
18.8
53
104
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
8.9
18.8
41
55
N03AX12
ATC
gabapentin; oral
5.3
18.2
62
153
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
5.2
18.1
62
154
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
6.4
17.8
50
97
A41.9
ICD-10 Finland
Sepsis, unspecified
10.0
17.8
36
42
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
19.5
17.4
26
15
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
12.7
17.4
31
28
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
13.7
16.9
29
24
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
16.9
16
*
I50.9
ICD-10 Finland
Heart failure, unspecified
4.3
16.4
70
216
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
25.6
15.4
21
9
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
48.8
15.3
18
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.5
15.2
90
364
B01AC04
ATC
clopidogrel; oral
4.1
15.0
68
219
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
20.2
15.0
22
12
PE1AT
NOMESCO Finland
Femoral artery PTA
61.1
15.0
17
*
X58
ICD-10 Finland
Exposure to other specified factors
4.7
14.8
55
146
NFQ48
NOMESCO Finland
Revision of exarticulation or amputation stump of hip or femur
+∞
14.7
14
*
Y83.5
ICD-10 Finland
Amputation of limb(s) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
14.7
14
*
QDA10
NOMESCO Finland
Incision of skin of lower limb
39.0
14.7
18
5
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
160.2
14.6
15
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.6
14.6
79
295
SPAT1149
SPAT
Suture or treatment of traumatic wound
4.9
14.5
51
128
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
10.5
14.5
28
30
SPAT1255
SPAT
Intravenous administration of medicine
6.7
14.3
37
64
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
9.0
14.1
30
38
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
19.2
14.1
21
12
NDQ20
NOMESCO Finland
Amputation of finger
57.2
14.0
16
*
103
Kela drug reimbursment
Diabetes, insulin-treated
3.2
14.0
96
426
J01MA12
ATC
levofloxacin; systemic
3.8
13.8
66
221
WX872
NOMESCO Finland
Intensive care
9.8
13.5
27
31
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
11.1
13.4
25
25
A28
ICPC
Limited function/disability NOS
3.7
12.9
63
214
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
11.1
12.9
24
24
PD4CC
NOMESCO Finland
Very extensive arterigography of lower extremity with X-ray
74.3
12.7
14
*
J01DB01
ATC
cefalexin; oral
3.8
12.7
189
1381
WX320
NOMESCO Finland
Spinalanesthesy
3.4
12.7
71
268
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
4.3
12.7
50
140
T87.5
ICD-10 Finland
Necrosis of amputation stump
+∞
12.6
12
*
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
+∞
12.6
12
*
S88.1
ICD-10 Finland
Traumatic amputation at level between knee and ankle
+∞
12.6
12
*
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
+∞
12.6
12
*
NG4AA
NOMESCO Finland
Lower leg X-ray examination
10.6
12.6
24
25
A10AA02
ATC
NA
8.1
12.5
28
39
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.8
12.5
44
110
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.7
12.4
60
201
SPAT1229
SPAT
Assessment of need for aid
5.8
12.4
36
72
A10AE05
ATC
insulin detemir; parenteral
6.4
12.4
33
59
NGM10
NOMESCO Finland
Fasciotomy of of knee or lower leg
40.0
12.4
15
*
I74.3
ICD-10 Finland
Embolism and thrombosis of arteries of lower extremities
28.6
12.2
16
6
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
49.5
12.0
14
*
S18
ICPC
Laceration/cut
2.8
11.9
111
587
ZXE10
NOMESCO Finland
More than one and less than three hours
2.9
11.8
99
490
ZXE20
NOMESCO Finland
More than three and less than five hours
4.2
11.8
48
138
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
24.5
11.7
16
7
M86.6
ICD-10 Finland
Other chronic osteomyelitis
68.7
11.7
13
*
E87.5
ICD-10 Finland
Hyperkalaemia
12.8
11.6
20
17
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
7.5
11.6
27
40
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
16.2
11.5
18
12
ZXE00
NOMESCO Finland
One hour or less
2.8
11.4
105
546
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.0
11.4
82
366
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
6.3
11.2
30
54
H3601, E113
ICD-10 Finland
NA
15.0
11.2
18
13
L03.9
ICD-10 Finland
Cellulitis, unspecified
15.0
11.2
18
13
I25.1
ICD-10 Finland
Atherosclerotic heart disease
3.0
11.2
83
376
PEH56
NOMESCO Finland
Bypass from femoral to popliteal artery above knee
45.8
11.0
13
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
19.0
10.9
16
9
R02
ICD-10 Finland
Gangrene, not elsewhere classified
63.1
10.7
12
*
QWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of skin
63.1
10.7
12
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.7
10.6
109
596
QDG99
NOMESCO Finland
Other operation for chronic ulcer or fistula of skin of lower limb
115.3
10.5
11
*
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
115.3
10.5
11
*
J04AB02
ATC
rifampicin; systemic
+∞
10.5
10
*
H3603, E113
ICD-10 Finland
NA
20.0
10.4
15
8
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
14.1
10.3
17
13
L14
ICPC
Leg/thigh symptom/complaint
5.3
10.1
31
66
I50.0
ICD-10 Finland
Congestive heart failure
4.3
10.1
38
101
QDB99
NOMESCO Finland
Other procedure for wound of skin of lower limb
42.1
10.1
12
*
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
10.3
10.0
19
20
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
10.3
10.0
19
20
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
21.2
9.9
14
7
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
27.5
9.9
13
5
PE1BT
NOMESCO Finland
Femoral artery extensive PTA
27.5
9.9
13
5
L28
ICPC
Limited function/disability (L)
3.3
9.9
55
203
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.6
9.9
47
154
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.7
9.8
28
55
WX210
NOMESCO Finland
Plexus blockade of nervus ichiadicus
57.6
9.7
11
*
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
7.2
9.7
23
35
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
16.0
9.7
15
10
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.8
9.6
75
344
N18.8
ICD-10 Finland
Other chronic renal failure
7.5
9.6
22
32
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
9.3
9.5
19
22
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
31.6
9.5
12
*
SPAT1151
SPAT
Treatment of major wounds
31.6
9.5
12
*
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
31.6
9.5
12
*
NH3CG
NOMESCO Finland
Extensive MRI of foot
104.3
9.5
10
*
NHS99
NOMESCO Finland
Other operation for infection of tendon, joint or bone of ankle or foot
104.3
9.5
10
*
NHQ60
NOMESCO Finland
Revision of ampution or exarticulation of ankle or foot
+∞
9.4
9
*
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
9.4
9
*
T87.2
ICD-10 Finland
Complications of other reattached body part
+∞
9.4
9
*
C07AB07
ATC
bisoprolol; oral
2.5
9.4
126
780
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.6
9.3
86
436
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.7
9.2
18
20
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
6.3
9.2
24
42
J01CF05
ATC
flucloxacillin; systemic
8.0
9.2
20
27
T36
ICD-10 Finland
Poisoning by systemic antibiotics
7.4
9.1
21
31
H43.1
ICD-10 Finland
Vitreous haemorrhage
9.2
9.0
18
21
A10AA01
ATC
NA
8.2
8.9
19
25
S76
ICPC
Skin infection other
5.6
8.8
25
49
PE1YT
NOMESCO Finland
Femoral or popliteal artery PTA with stent
28.8
8.6
11
*
S19
ICPC
Skin injury other
6.7
8.6
21
34
AA1AD
NOMESCO Finland
CT of head and brain
2.7
8.5
70
329
H36.01
ICD-10 Finland
Diabetic maculopathy
13.5
8.5
14
11
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
93.5
8.5
9
*
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
93.5
8.5
9
*
M86.4
ICD-10 Finland
Chronic osteomyelitis with draining sinus
93.5
8.5
9
*
B01AA03
ATC
warfarin; systemic
2.7
8.4
71
336
T87.0
ICD-10 Finland
Complications of reattached (part of) upper extremity
+∞
8.4
8
*
L98
ICPC
Acquired deformity of limb
+∞
8.4
8
*
L17
ICPC
Foot/toe symptom/complaint
2.7
8.3
64
288
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
15.2
8.3
13
9
A11CC03
ATC
alfacalcidol; systemic
7.3
8.3
19
28
J01DA01
ATC
[U] cefalexin; systemic
2.4
8.3
147
1019
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
18.0
8.2
12
7
L03.0
ICD-10 Finland
Cellulitis of finger and toe
4.4
8.2
29
73
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
8.3
8.0
17
22
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.6
7.9
27
65
CKC12
NOMESCO Finland
Photocoagulation of retina
5.3
7.9
23
47
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
7.9
7.8
17
23
Y88.1
ICD-10 Finland
Sequelae of misadventures to patients during surgical and medical procedures
46.6
7.8
9
*
S68.1
ICD-10 Finland
Traumatic amputation of other single finger (complete)(partial)
46.6
7.8
9
*
QDE35
NOMESCO Finland
Repair of skin defect in lower limb after surgery or injury
46.6
7.8
9
*
QD6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in foot
46.6
7.8
9
*
C09AA05
ATC
ramipril; oral
2.5
7.7
70
345
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.4
7.7
38
127
WX702
NOMESCO Finland
Supraglottic ventilation device
6.2
7.7
20
35
I79.2*E11.5
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
19.2
7.7
11
6
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
4.1
7.6
29
78
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
6.9
7.6
18
28
T89
ICPC
Diabetes insulin dependent
6.0
7.6
20
36
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
7.6
107
654
AN1
HP
Coronary angiography
3.0
7.5
46
179
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
3.6
7.5
34
107
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
82.7
7.5
8
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.2
7.4
110
684
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
6.7
7.4
18
29
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.1
7.4
28
75
B01AB05
ATC
enoxaparin; parenteral
2.4
7.4
77
405
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
11.4
7.4
13
12
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
4.3
7.4
27
70
QDG00
NOMESCO Finland
Debridement of bedsore of lower limb
+∞
7.3
7
*
T87.1
ICD-10 Finland
Complications of reattached (part of) lower extremity
+∞
7.3
7
*
PFP99
NOMESCO Finland
Percutaneous plastic repair of artery of lower leg
+∞
7.3
7
*
M86.8
ICD-10 Finland
Other osteomyelitis
+∞
7.3
7
*
Z44.1
ICD-10 Finland
Fitting and adjustment of artificial leg (complete)(partial)
+∞
7.3
7
*
Z89.6
ICD-10 Finland
Acquired absence of leg above knee
+∞
7.3
7
*
I79.2*E10.5
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
+∞
7.3
7
*
PWE00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system
+∞
7.3
7
*
T82.7
ICD-10 Finland
Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts
+∞
7.3
7
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.5
7.3
65
316
J01MA14
ATC
moxifloxacin; systemic
3.8
7.3
30
87
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
7.0
7.3
17
26
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
31.1
7.2
9
*
WX214
NOMESCO Finland
Plexus blockade at the ankle
20.8
7.2
10
5
S91.3
ICD-10 Finland
Open wound of other parts of foot
9.3
7.2
14
16
TPH07
NOMESCO Finland
Cathetrisation of artery
3.4
7.1
35
117
B03XA02
ATC
darbepoetin alfa; parenteral
10.5
7.1
13
13
S17
ICPC
Abrasion/scratch/blister
10.5
7.1
13
13
SPAT1262
SPAT
Handing over of treatment supplies
2.6
7.1
57
260
ZXA10
NOMESCO Finland
Bilateral
2.7
7.0
52
228
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
7.0
59
279
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
6.5
6.9
17
28
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
6.9
39
144
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
11.5
6.9
12
11
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
6.9
76
411
TQW40
NOMESCO Finland
Remowal of suture of skin
4.5
6.9
23
55
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
5.5
6.8
19
37
QCB05
NOMESCO Finland
Revision of wound of skin of upper limb
17.4
6.8
10
6
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.9
6.8
21
46
NDQ48
NOMESCO Finland
Revision or amputation or exarticulation of finger
41.3
6.8
8
*
T90
ICPC
Diabetes non-insulin dependent
2.4
6.8
66
334
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.4
6.8
33
110
SPAT1104
SPAT
Monitoring of emergency patient
4.1
6.7
25
66
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.7
6.7
47
198
X57
ICD-10 Finland
Unspecified privation
12.8
6.7
11
9
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
12.8
6.7
11
9
A10BB12
ATC
glimepiride; oral
3.7
6.6
28
83
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
7.2
6.6
15
22
TK800
NOMESCO Finland
Hemodialysis
7.8
6.5
14
19
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
7.8
6.5
14
19
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.3
6.5
66
340
PWG00
NOMESCO Finland
Reoperation on peripheral vessels for thrombosis or embolism
71.8
6.5
7
*
PEH57
NOMESCO Finland
Bypass from femoral artery to popliteal artery below knee
71.8
6.5
7
*
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
14.9
6.5
10
7
S91.1
ICD-10 Finland
Open wound of toe(s) without damage to nail
14.9
6.5
10
7
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.9
6.5
15
23
A01
ICPC
Pain general/multiple sites
4.1
6.4
24
64
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
4.1
6.4
24
64
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.4
6.4
22
54
N05AA02
ATC
levomepromazine; systemic
5.1
6.4
19
40
A02BC01
ATC
omeprazole; systemic
2.2
6.4
73
399
H3603, E103
ICD-10 Finland
NA
9.7
6.4
12
13
ZXE40
NOMESCO Finland
More than seven and less than nine hours
11.5
6.4
11
10
C01DA14
ATC
isosorbide mononitrate; oral
2.4
6.3
56
270
SPAT1254
SPAT
Administration of medicine
2.8
6.3
42
170
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.3
6.3
67
352
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.7
6.3
45
191
C10AA01
ATC
simvastatin; oral
2.1
6.3
112
738
NHQ20
NOMESCO Finland
Amputation of ankle
+∞
6.3
6
*
M14.6*E10.6
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic neuropathic
+∞
6.3
6
*
NGQ10
NOMESCO Finland
Exarticulation of knee
+∞
6.3
6
*
M14.6*E11.6
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic neuropathic
+∞
6.3
6
*
NHQ48
NOMESCO Finland
Revision of amputation of toe
+∞
6.3
6
*
QXB10
NOMESCO Finland
Exchange of dressing for large skin wound, unspecified location
+∞
6.3
6
*
G54.6
ICD-10 Finland
Phantom limb syndrome with pain
+∞
6.3
6
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
5.2
6.2
18
37
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
5.5
6.2
17
33
Z49.1
ICD-10 Finland
Extracorporeal dialysis
9.0
6.1
12
14
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.8
6.1
41
169
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
7.6
6.0
13
18
H02AB06
ATC
prednisolone; systemic
2.0
6.0
104
674
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
104
192
8.87
60.06
5.3
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
110
248
7.41
51.66
5.9
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
27
22
13.72
27.70
1.5
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
123
512
3.92
24.06
9.3
4.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
50
129
4.64
18.46
2.4
1.4
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
33
66
5.65
16.26
3.6
2.0
ug/l
309.1
357.5
0.14
33
61
(3003396) Base excess in Arterial blood by calculation
59
203
3.54
14.41
11.1
6.2
mmol/l
1.2
1.0
0.13
50
160
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
22
38
6.28
12.51
3.4
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
89
423
2.77
12.20
3.4
2.0
mg/l
3.6
3.3
0.33
81
364
(3012095) Magnesium [Moles/volume] in Serum or Plasma
68
289
2.90
11.42
6.8
3.1
mmol/l
0.8
0.8
0.02
62
270
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
62
251
2.99
11.36
5.0
2.1
%
22.3
22.7
0.05
52
218
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
128
748
2.55
11.29
8.9
3.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
100
524
2.57
11.07
5.8
2.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
50
188
3.10
10.36
7.2
3.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
126
758
2.41
10.08
24.5
9.3
inr
1.4
1.3
0.38
34
212
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
98
544
2.37
9.22
4.0
2.2
u/l
53.7
56.9
0.27
89
497
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
66
306
2.60
9.17
2.8
1.9
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
44
172
2.91
8.43
2.8
2.6
ug/l
4.5
8.0
1.02
38
150
(3000991) Gas panel - Venous blood
41
154
3.01
8.43
11.4
6.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
27
81
3.63
7.93
12.0
8.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
121
783
2.11
7.38
11.6
3.9
g/l
30.6
35.3
10.90
112
737
(3002032) Base excess in Venous blood by calculation
43
180
2.70
7.21
11.5
3.3
mmol/l
1.3
2.1
0.61
37
136
(3019060) Gas panel - Arterial blood
33
120
3.03
7.15
12.3
4.6
—
—
—
0
0
(3012544) pH of Venous blood
43
184
2.63
6.90
11.7
3.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
17
6.74
6.84
1.0
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
72
395
2.18
6.61
5.9
2.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
65
343
2.23
6.56
5.3
3.5
ng/l
639.4
210.2
0.36
57
268
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
48
224
2.43
6.41
2.3
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
92
560
2.05
6.40
3.8
2.9
u/l
26.5
32.5
2.22
86
528
(3017143) Hepatitis C virus Ab [Presence] in Serum
38
159
2.66
6.35
2.6
1.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
132
917
1.99
6.29
7.1
5.8
umol/l
10.4
11.6
1.13
124
860
(3026008) Bacteria identified in Urine by Culture
87
522
2.05
6.27
4.0
3.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
16
39
4.33
6.19
3.8
3.1
nmol/l
1.0
0.8
0.38
11
34
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
40
175
2.55
6.11
2.6
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
48
229
2.37
6.09
2.7
1.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
127
878
1.96
6.06
8.7
5.8
e9/l
0.2
0.2
1.09
112
777
(3022217) INR in Platelet poor plasma by Coagulation assay
52
258
2.30
6.04
39.8
21.6
inr
1.6
1.4
—
9
31
(3022096) Basophils/100 leukocytes in Blood
116
781
1.95
5.95
8.0
5.7
%
0.6
0.6
0.03
105
727
(3006504) Eosinophils/100 leukocytes in Blood
118
801
1.94
5.89
8.1
5.7
%
2.8
2.8
0.02
106
745
(3019069) Monocytes/100 leukocytes in Blood
118
806
1.92
5.74
8.4
6.0
%
8.3
8.6
0.48
106
756
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
46
222
2.33
5.67
2.4
1.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
34
143
2.61
5.62
4.8
2.8
g/l
66.0
66.2
0.06
27
129
(3026493) Urate [Moles/volume] in Serum or Plasma
80
482
2.00
5.60
3.4
2.7
umol/l
11249.2
7746.2
0.12
71
403
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
18
52
3.66
5.57
1.2
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
122
857
1.87
5.32
8.4
5.5
e9/l
0.0
0.0
1.58
107
757
(3002030) Lymphocytes/100 leukocytes in Blood
118
821
1.87
5.29
8.6
5.9
%
21.2
26.8
7.22
105
766
(3018010) Neutrophils/100 leukocytes in Blood
117
812
1.87
5.29
8.2
5.7
%
63.9
58.0
6.37
105
765
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
35
4.19
5.25
1.4
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
35
4.19
5.25
1.4
1.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
121
853
1.86
5.17
8.3
5.5
e9/l
0.7
0.6
4.92
106
748
(44790047)
11
23
4.97
5.06
1.5
1.4
—
—
—
0
0
(44806118)
11
23
4.97
5.06
1.5
1.4
—
—
—
0
0
(44790048)
11
23
4.97
5.06
1.5
1.4
—
—
—
0
0
(44790049)
11
23
4.97
5.06
1.5
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
122
874
1.82
4.85
8.9
5.6
e9/l
1.6
1.9
1.57
109
780
(42870588) Differential panel, method unspecified - Blood
89
583
1.84
4.71
7.7
5.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
29
123
2.55
4.71
2.1
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
15
43
3.66
4.69
1.2
3.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
91
602
1.83
4.65
3.8
3.0
ng/l
3786.9
1542.0
1.16
82
504
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
104
723
1.78
4.47
2.4
2.0
pmol/l
95.8
92.5
0.32
59
372
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
27
114
2.54
4.42
5.7
3.7
mmol/l
2.0
1.7
0.16
20
85
(3000494) Fungus identified in Specimen by Culture
42
216
2.15
4.42
2.2
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
11
26
4.39
4.40
2.2
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
23
90
2.72
4.37
2.5
1.8
g/l
2.1
1.6
0.87
17
79
(3001122) Ferritin [Mass/volume] in Serum or Plasma
102
709
1.77
4.36
5.5
2.4
ug/l
207.7
155.7
1.10
96
649
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
9
9.15
4.31
5.8
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
36
653
0.47
4.27
3.9
3.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
27
117
2.48
4.20
2.3
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
16
52
3.23
4.17
7.0
3.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
28
4.07
4.02
2.2
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
14
6.63
4.02
5.0
3.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
60
363
1.87
4.00
2.1
1.8
nmol/l
1308.1
1207.2
0.39
52
282
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
120
890
1.71
3.97
21.3
6.0
mmol/l
1.2
1.2
3.47
107
738
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
61
373
1.86
3.93
2.7
1.6
mg/l
1.4
1.2
0.25
52
305
(3009508) Creatinine [Moles/volume] in Urine
80
534
1.75
3.84
5.2
3.1
mmol/l
6.7
7.9
1.70
69
436
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
34
3.66
3.82
4.3
1.8
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
14
46
3.17
3.59
1.3
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
60
378
1.79
3.47
6.7
4.0
kg/l
1.0
1.0
0.05
14
50
(3020891) Body temperature
19
76
2.63
3.47
15.9
4.5
—
—
—
0
0
(3017704) Immunofixation for Urine
7
10
7.17
3.38
1.3
1.8
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
14
5.87
3.37
1.1
1.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
28
137
2.18
3.33
7.3
3.2
ml/min/173m2
54.2
62.6
0.54
17
56
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
19
4.88
3.27
1.0
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
108
811
1.61
3.20
16.1
5.2
mmol/l
1.2
1.2
3.49
102
718
(3020682) Albumin/Creatinine [Ratio] in Urine
80
559
1.65
3.16
5.5
4.1
mg/mmol
38.7
8.1
2.67
63
368
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
39
3.19
3.13
1.7
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
17
68
2.62
3.12
3.8
2.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
75
517
1.66
3.11
4.7
3.2
mg/l
212.7
57.8
1.86
57
341
(40758558) Short blood count panel - Blood
64
423
1.70
3.11
12.6
6.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
26
480
0.49
3.11
1.8
3.1
ug/l
0.4
0.8
2.54
14
317
(3024928) Oxygen saturation in Venous blood
11
34
3.34
3.10
9.5
2.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
21
4.41
3.02
1.6
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
5
10.17
2.99
2.4
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
13
47
2.87
2.86
5.8
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
150
1735
0.63
2.83
5.9
4.7
mmol/l
7.1
6.0
4.51
137
1566
(3000764) Benzodiazepines [Presence] in Urine
13
48
2.81
2.76
5.8
1.7
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
6
8.48
2.76
2.0
1.8
—
—
—
0
0
(4198724)
5
6
8.48
2.76
1.4
1.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
125
995
1.54
2.75
11.7
8.8
e9/l
5.3
4.2
4.99
110
875
(3028707) Methadone [Presence] in Urine by Screen method
8
19
4.32
2.70
5.9
2.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
56
370
1.67
2.70
4.8
3.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
13
49
2.75
2.67
4.3
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
159
1806
0.64
2.61
6.2
5.1
mmol/l
2.3
2.7
4.31
149
1637
(40761535) Cells panel - Urine sediment
28
151
1.97
2.60
5.8
3.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
35
204
1.84
2.59
2.4
2.4
umol/l
4.8
9.2
2.74
29
182
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
56
2.59
2.58
1.6
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
56
2.59
2.58
1.6
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
13
50
2.69
2.58
6.0
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
13
50
2.69
2.58
5.8
1.6
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
5
7
7.27
2.56
1.2
1.1
g/l
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
16
4.47
2.49
1.4
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
64
447
1.59
2.46
2.2
1.5
nmol/l
16.1
21.4
2.26
59
365
(3011288) Drugs identified in Urine by Screen method
9
27
3.42
2.42
10.7
2.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
12
5.10
2.41
1.0
1.0
—
—
—
0
0
(4306422)
6
12
5.10
2.41
1.2
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
16
71
2.34
2.40
3.3
2.9
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
35
210
1.78
2.37
1.3
1.4
titre
640.0
491.3
—
5
53
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
155
1759
0.66
2.36
5.3
4.5
mmol/l
1.2
1.4
7.38
145
1596
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
10
35
2.94
2.33
1.5
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
90
689
1.49
2.27
3.5
2.1
nmol/l
70.6
76.1
1.25
81
605
(3018418) pH of Serum or Plasma
73
535
1.53
2.26
11.1
3.5
ph
7.4
7.4
—
8
109
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
36
2.86
2.23
1.8
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
19
3.76
2.16
1.1
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
57
0.00
2.08
0.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
10
5.08
2.08
2.4
1.7
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
10
5.08
2.08
5.6
9.9
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
19
97
2.04
2.07
6.7
2.3
%
1.6
1.1
0.44
19
97
(3015377) Calcium [Moles/volume] in Serum or Plasma
78
590
1.48
2.05
5.4
3.1
mmol/l
2.3
2.3
3.68
67
505
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
14
63
2.30
2.05
3.8
1.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
70
2.22
2.03
1.6
2.6
g/l
8.1
7.4
—
10
53
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
70
2.22
2.03
1.6
2.6
g/l
3.9
3.6
—
9
50
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
70
2.22
2.03
1.6
2.6
—
—
—
0
0
(3026782) Osmolality of Urine
53
370
1.56
2.02
3.9
3.0
mosm/kgh2o
494.8
573.7
2.43
48
311
(3004588) Protein electrophoresis panel - Serum or Plasma
23
127
1.90
2.02
1.5
2.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
158
1769
0.68
2.02
5.5
4.6
mmol/l
4.1
4.5
5.41
149
1617
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
62
822
0.67
1.99
3.0
5.0
ug/l
1.7
2.8
1.47
51
737
(21494755) Public health laboratory ask at order entry panel
5
141
0.34
1.96
1.2
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
11
4.62
1.95
1.4
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
152
1710
0.69
1.94
5.0
4.1
mmol/l
1.6
1.3
4.29
142
1544
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
17
3.59
1.85
2.0
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
35
2.63
1.82
1.7
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
35
2.63
1.82
1.8
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
48
656
0.66
1.76
3.3
4.6
%
23.0
21.0
0.30
20
314
(3021901) Oxygen saturation in Capillary blood
9
36
2.56
1.76
3.8
2.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
18
3.39
1.76
1.3
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
7
162
0.41
1.74
1.3
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
11
48
2.35
1.73
1.2
1.3
—
—
—
0
0
(4268621)
5
13
3.90
1.72
2.0
1.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
84
666
1.40
1.67
5.6
3.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
31
2.63
1.67
1.9
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
17
91
1.94
1.65
1.1
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
14
3.62
1.62
11.2
2.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
14
3.62
1.62
1.0
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
29
433
0.62
1.59
2.6
1.6
mmol/l
1.9
1.4
2.04
23
360
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
140
0.41
1.58
1.2
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
54
707
0.69
1.56
2.0
2.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
44
2.33
1.55
1.1
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
157
1391
1.38
1.54
12.2
7.0
u/l
85.7
79.0
0.99
149
1283
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
15
3.38
1.53
1.2
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
15
3.38
1.53
1.0
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
80
638
1.38
1.52
5.4
3.8
e6/l
93.4
81.2
0.12
64
474
(3037467) Urinalysis macro (dipstick) panel - Urine
137
1190
1.36
1.51
6.1
4.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
37
2.49
1.49
4.6
3.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
18
102
1.83
1.49
2.1
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
6
22
2.77
1.44
1.3
1.1
u/ml
438.3
312.5
—
6
12
(3030467) Casts [#/volume] in Urine by Automated count
65
505
1.40
1.44
5.2
3.1
e6/l
0.7
0.4
0.47
55
380
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
40
2.30
1.41
1.9
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
29
2.46
1.40
1.3
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
63
489
1.39
1.40
5.0
3.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
41
2.24
1.38
1.3
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
23
2.65
1.37
1.0
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
71
564
1.37
1.37
5.1
3.3
e6/l
46.3
160.1
0.50
59
442
(3045788) Cell count panel - Pleural fluid
5
17
2.98
1.36
1.0
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
17
2.98
1.36
2.0
2.7
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
13
68
1.96
1.36
20.0
4.0
mmol/l
4.0
4.0
0.01
13
61
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
24
2.54
1.31
1.0
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
60
468
1.38
1.29
5.6
4.1
estimate
0.0
0.0
0.00
14
157
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
18
2.81
1.29
1.2
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
44
2.09
1.28
1.6
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
25
2.44
1.25
1.3
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
45
2.04
1.24
1.6
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
45
2.04
1.24
1.6
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
19
2.67
1.22
1.0
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
53
412
1.37
1.16
2.0
1.8
pmol/l
197872761.1
428.2
0.49
47
331
(40768806) Pleura Pathology biopsy report
5
20
2.53
1.15
1.2
1.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
21
2.41
1.09
11.4
2.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
82
1.75
1.07
3.1
2.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
156
1692
0.77
1.07
36.0
13.2
ml/min/173m2
73.5
78.1
1.16
133
1400
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
179
1906
0.75
1.06
17.4
10.0
u/l
25.8
26.4
0.18
173
1834
(3026361) Erythrocytes [#/volume] in Blood
187
1979
0.74
1.06
68.1
20.3
e12/l
4.2
4.5
8.93
179
1909
(3000963) Hemoglobin [Mass/volume] in Blood
187
1979
0.74
1.06
68.6
20.4
g/l
123.0
136.6
16.41
181
1940
(3010813) Leukocytes [#/volume] in Blood
187
1979
0.74
1.06
68.3
20.4
e9/l
8.2
6.7
10.88
178
1909
(40760892) CBC W Ordered Manual Differential panel - Blood
48
373
1.36
1.06
6.8
4.4
—
—
—
0
0
(3035941) MCH [Entitic mass]
187
1978
0.74
1.04
67.9
20.2
pg
30.0
30.4
2.22
181
1940
(3035637) Corticotropin [Mass/volume] in Plasma
5
22
2.30
1.04
1.0
1.5
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
22
2.30
1.04
1.0
1.8
pg
32.0
32.2
—
5
22
(3024731) MCV [Entitic volume]
187
1977
0.74
1.03
67.9
20.3
fl
91.0
91.3
0.37
181
1939
(3007461) Platelets [#/volume] in Blood
187
1977
0.74
1.03
68.2
20.3
e9/l
262.4
241.2
2.52
179
1916
(3014051) Protein [Presence] in Urine by Test strip
7
35
2.03
1.01
2.6
2.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
49
1.87
1.00
3.4
1.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
15
92
1.67
0.99
8.3
3.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
36
1.97
0.98
1.0
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
147
1597
0.79
0.96
5.0
4.4
mu/l
1.7
2.0
1.92
136
1416
(3035350) Ketones [Presence] in Urine by Test strip
99
860
1.26
0.96
5.6
3.7
estimate
0.0
0.0
0.00
16
163
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
128
1147
1.25
0.94
4.9
2.9
u/l
94.3
48.6
2.15
120
1074
(40768443) Skin Pathology biopsy report
12
70
1.75
0.94
1.2
1.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
27
2.25
0.94
2.2
1.6
%
83.3
90.8
—
6
27
(4035726)
9
155
0.56
0.92
1.9
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
112
991
1.25
0.92
3.3
2.7
—
—
—
0
0
(3019225) pH of Specimen
25
178
1.45
0.91
11.8
4.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
47
1.73
0.81
1.9
1.6
—
—
—
0
0
(3000492) Spirometry study
10
161
0.60
0.78
1.6
1.5
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
24
2.11
0.75
1.2
2.3
u/ml
3.2
156.7
—
5
24
(3013707) Erythrocyte sedimentation rate by Westergren method
143
1318
1.21
0.74
6.6
4.0
mm/h
25.8
13.0
6.38
137
1208
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
38
303
1.30
0.72
4.2
2.7
e6/l
1.0
1.1
0.17
26
174
(4034850)
9
57
1.60
0.72
33.0
10.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
26
1.94
0.71
1.8
2.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7
119
0.58
0.69
2.6
2.4
—
13.5
—
0
8
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
27
1.87
0.69
1.8
2.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
27
1.87
0.69
2.4
3.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
20
145
1.41
0.68
4.7
4.2
%
0.9
0.7
—
10
52
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
85
750
1.21
0.68
8.1
3.9
ng/l
55.2
49.4
0.17
69
559
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
12
175
0.67
0.63
1.7
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
36
291
1.28
0.63
4.5
3.0
e6/l
3.4
1.6
1.10
24
167
(3045414) Leukocytes [Presence] in Urine
10
63
1.61
0.63
3.1
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
13
186
0.68
0.62
1.3
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
78
688
1.20
0.62
6.1
3.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
51
431
1.23
0.62
1.6
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
30
1.68
0.62
1.0
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
96
864
1.19
0.61
7.5
5.0
estimate
0.0
0.0
0.00
15
163
(40768795) Lymph node Pathology biopsy report
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
97
877
1.18
0.58
5.8
3.7
estimate
0.0
0.0
0.00
17
155
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
39
1.55
0.53
1.5
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
30
245
1.26
0.50
1.3
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7
107
0.64
0.50
1.4
1.3
—
34.8
—
0
9
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
45
1.57
0.49
1.1
1.2
—
2.7
—
0
9
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
45
1.57
0.49
1.1
1.2
—
4.2
—
0
8
(3044889) 12 lead EKG panel
133
1247
1.15
0.47
5.0
4.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
50
1.41
0.45
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
50
1.41
0.45
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
50
1.41
0.45
1.3
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
128
0.69
0.44
1.3
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
185
1782
1.17
0.43
55.4
13.8
mg/l
34.1
24.7
3.17
166
1392
(3044290) Cell count panel - Cerebral spinal fluid
5
31
1.63
0.43
1.4
1.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
5
32
1.57
0.42
2.6
1.7
mmol/l
1.5
1.7
—
5
32
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
16
0.00
0.41
0.0
1.0
—
36.8
—
0
8
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
478.1
—
0
8
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
268.3
—
0
8
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.5
—
0.2
—
0
12
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
41
1.48
0.36
1.3
1.5
—
—
—
0
0
(1002224) Polysomnography panel
5
78
0.63
0.36
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
80
0.62
0.36
4.4
2.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
42
1.44
0.36
1.2
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
6
42
1.44
0.36
1.2
1.2
—
16.8
—
0
6
(3021589) Normoblasts [#/volume] in Blood
84
780
1.12
0.32
17.8
9.2
e9/l
0.0
0.0
0.40
69
649
(3002256) Pathology report gross observation
18
217
0.82
0.30
1.7
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
223
1.19
0.30
29.3
7.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
104
1.26
0.27
5.1
4.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
38
1.32
0.23
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
164
1594
1.09
0.23
43.3
14.4
%
37.0
40.1
2.71
100
1104
(3041096) Erythrocytes [Presence] in Urine by Automated
46
499
0.90
0.21
5.8
3.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
103
0.77
0.21
1.1
1.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
11
0.00
0.21
0.0
1.5
—
13.4
—
0
11
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.3
—
57.5
—
0
10
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(44806420)
0
10
0.00
0.21
0.0
2.6
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
1.1
—
0
10
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
37
336
1.12
0.21
1.5
1.2
u/ml
2.7
1.8
—
8
90
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
0.3
—
0
6
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
2.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
2.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
13
0.00
0.21
0.0
2.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
2.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
2.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
80
1.26
0.21
1.3
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
99
1.22
0.20
1.8
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
51
1.18
0.19
1.3
1.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
183
1865
0.92
0.18
45.8
13.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
14
119
1.19
0.18
4.0
2.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
36
331
1.10
0.17
2.0
2.9
mmol/l
2.5
2.4
0.10
30
295
(1761482) Bacteria [#/volume] in Urine by Culture
5
67
0.74
0.17
5.6
5.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
15
130
1.16
0.16
5.3
4.4
%
0.0
0.2
—
5
43
(36660697) Celiac disease serology panel - Serum
13
113
1.16
0.13
1.3
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
29
268
1.09
0.13
1.1
1.3
u/ml
2.7
14.0
—
9
109
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
13
115
1.14
0.10
1.7
1.7
—
—
—
0
0
(4010399)
12
134
0.89
0.09
1.4
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
184
1860
0.95
0.08
55.5
16.2
mmol/l
4.1
4.0
1.61
179
1802
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
126
1280
0.97
0.07
3.7
3.6
pmol/l
15.3
14.9
0.94
115
1139
(3019832) Treponema pallidum Ab [Presence] in Serum
8
92
0.87
0.07
1.8
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
15
138
1.09
0.06
5.5
4.3
%
0.0
0.1
—
7
47
(3013512) EKG study
56
577
0.96
0.06
6.9
4.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
14
151
0.92
0.05
5.9
3.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
30
288
1.05
0.04
1.2
1.3
iu/ml
74.7
32.3
—
9
101
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
166
1670
0.98
0.02
9.7
6.2
mmol/mol
49.3
40.7
8.04
153
1547
(3007164) IgA [Mass/volume] in Serum or Plasma
31
309
1.00
0.00
1.7
1.4
g/l
3.1
2.8
0.21
20
189
(3019550) Sodium [Moles/volume] in Serum or Plasma
185
1852
1.00
0.00
55.2
16.2
mmol/l
138.7
139.7
5.61
180
1793
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
24
244
0.98
0.00
1.2
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
72
0.97
0.00
1.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.6
—
4.1
—
0
5
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
1408.7
—
0
7
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
39.4
—
0
5
(3024471) HLA-A [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
53
0.94
0.00
1.2
1.6
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
3.7
—
0
5
(4211845)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.8
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
0.00
0.0
6.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
6
69
0.87
0.00
1.3
1.7
mg/l
6.2
2.3
—
6
49
(3001019) Free T4 and TSH panel - Serum or Plasma
7
70
1.00
0.00
2.7
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
63
0.95
0.00
1.5
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_COMPLICATIO_PECUL_REATTACHM_AMPUT – Complications peculiar to reattachment and amputation
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).